600713
vs
S
Shanghai Composite
600713
Over the past 12 months, NanJing Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +8% compared to the Shanghai Composite's +23% growth.
Stocks Performance
600713 vs Shanghai Composite
Performance Gap
600713 vs Shanghai Composite
Performance By Year
600713 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
NanJing Pharmaceutical Co Ltd
Glance View
Nanjing Pharmaceutical Co., Ltd. engages in the service of pharmaceutical distribution. The company is headquartered in Nanjing, Jiangsu and currently employs 5,062 full-time employees. The firm's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The firm mainly conducts its business in domestic market.